IGC Pharma, Inc. (IGC)
NYSE: IGC · CIK 0001326205 · United States
Every official IGC Pharma, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open IGC filings
IGC Pharma, Inc. documents
- IGC Pharma, Inc. 10-K 2026IGC 10-K 2026: annual report for fiscal 2026
- IGC Pharma, Inc. 10-K 2025IGC 10-K 2025: annual report for fiscal 2025
- IGC Pharma, Inc. 10-K 2024IGC 10-K 2024: annual report for fiscal 2024
- IGC Pharma, Inc. 10-K 2023IGC 10-K 2023: annual report for fiscal 2023
- IGC Pharma, Inc. 10-K 2022IGC 10-K 2022: annual report for fiscal 2022
- IGC Pharma, Inc. 10-Q 2026IGC 10-Q 2026: quarterly report for fiscal 2026
- IGC Pharma, Inc. 10-Q 2025IGC 10-Q 2025: quarterly report for fiscal 2025
- IGC Pharma, Inc. 10-Q 2024IGC 10-Q 2024: quarterly report for fiscal 2024
- IGC Pharma, Inc. 10-Q 2023IGC 10-Q 2023: quarterly report for fiscal 2023
- IGC Pharma, Inc. 10-Q 2022IGC 10-Q 2022: quarterly report for fiscal 2022
- IGC Pharma, Inc. 8-K 2026IGC 8-K 2026: current report for fiscal 2026
- IGC Pharma, Inc. 8-K 2025IGC 8-K 2025: current report for fiscal 2025
- IGC Pharma, Inc. 8-K 2024IGC 8-K 2024: current report for fiscal 2024
- IGC Pharma, Inc. 8-K 2023IGC 8-K 2023: current report for fiscal 2023
- IGC Pharma, Inc. 8-K 2022IGC 8-K 2022: current report for fiscal 2022
- IGC Pharma, Inc. DEF 14A 2026IGC DEF 14A 2026: proxy statement for fiscal 2026
- IGC Pharma, Inc. DEF 14A 2025IGC DEF 14A 2025: proxy statement for fiscal 2025
- IGC Pharma, Inc. DEF 14A 2024IGC DEF 14A 2024: proxy statement for fiscal 2024
- IGC Pharma, Inc. DEF 14A 2023IGC DEF 14A 2023: proxy statement for fiscal 2023
- IGC Pharma, Inc. DEF 14A 2022IGC DEF 14A 2022: proxy statement for fiscal 2022
- IGC Pharma, Inc. Form 4 2026IGC Form 4 2026: insider trading filing for fiscal 2026
- IGC Pharma, Inc. Form 4 2025IGC Form 4 2025: insider trading filing for fiscal 2025
- IGC Pharma, Inc. Form 4 2024IGC Form 4 2024: insider trading filing for fiscal 2024
- IGC Pharma, Inc. Form 4 2023IGC Form 4 2023: insider trading filing for fiscal 2023
- IGC Pharma, Inc. Form 4 2022IGC Form 4 2022: insider trading filing for fiscal 2022
- IGC Pharma, Inc. S-1 2026IGC S-1 2026: registration statement for fiscal 2026
- IGC Pharma, Inc. S-1 2025IGC S-1 2025: registration statement for fiscal 2025
- IGC Pharma, Inc. S-1 2024IGC S-1 2024: registration statement for fiscal 2024
- IGC Pharma, Inc. S-1 2023IGC S-1 2023: registration statement for fiscal 2023
- IGC Pharma, Inc. S-1 2022IGC S-1 2022: registration statement for fiscal 2022
- IGC Pharma, Inc. 13F 2026IGC 13F 2026: institutional holdings for fiscal 2026
- IGC Pharma, Inc. 13F 2025IGC 13F 2025: institutional holdings for fiscal 2025
- IGC Pharma, Inc. 13F 2024IGC 13F 2024: institutional holdings for fiscal 2024
- IGC Pharma, Inc. 13F 2023IGC 13F 2023: institutional holdings for fiscal 2023
- IGC Pharma, Inc. 13F 2022IGC 13F 2022: institutional holdings for fiscal 2022
More companies